A discovery engine for the pharmaceutical industry
Motif BioSciences, Inc. is applying proprietary technology and expertise in medicinal chemistry, biology and genomics to discover and develop best-in-class small molecule drugs and novel genetic targets that can be partnered out to the pharmaceutical industry for further development.
Motif was founded on the scientific premise of studying the genetic causes of common, complex diseases in relatively small and specialized populations. This approach has been validated in important discoveries in diabetes and hypertension in partnership with Imperial College London.
Motif has built on this foundation by adding a very experienced team of drug discovery scientists – former senior executives at Merck, Schering Plough, Wyeth, GlaxoSmithKline, and Bayer - in medicinal and computational chemistry, biology, toxicology, pharmacology, and clinical development to capitalize on the growing trend of pharmaceutical companies to outsource drug discovery to small specialized players.
Motif Executive Summary
Corporate Overview